DB289 Versus TMP-SMX for the Treatment of Acute Pneumocystis Jiroveci Pneumonia (PCP)

This study has been suspended.

( FDA Clinical Hold as of 12/21/07 due to safety concerns )

Study NCT00302341 Information provided by Immtech Pharmaceuticals, Inc

First Received: March 10, 2006 Last Updated: January 28, 2008 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been suspended.
Estimated Study Completion Date:	May 2008
Estimated Primary Completion Date:	May 2008 (Final data collection date for primary outcome measure)